Altria Group, Inc.
http://www.altria.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Altria Group, Inc.
Looming E-Cigarette Regulation Could Shift Cessation Playing Field
Approval as smoking cessation products is an expensive option for e-cigarette firms due to the costs of preparing and submitting an NDA to FDA’s drug center. Regulation under the agency’s tobacco center could lead to modified risk status, but might make the NDA route more appealing.
Looming E-Cigarette Regulation Could Shift Cessation Playing Field
Approval as smoking cessation products is an expensive option for e-cigarette firms due to the costs of preparing and submitting an NDA to FDA’s drug center. Regulation under the agency’s tobacco center could lead to modified risk status, but might make the NDA route more appealing.
Looming E-Cigarette Regulation Could Shift Cessation Playing Field
Approval as smoking cessation products is an expensive option for e-cigarette firms due to the costs of preparing and submitting an NDA to FDA’s drug center. Regulation under the agency’s tobacco center could lead to modified risk status, but might make the NDA route more appealing.
Looming E-Cigarette Regulation Could Shift Cessation Playing Field
Approval as smoking cessation products is an expensive option for e-cigarette firms due to the costs of preparing and submitting an NDA to FDA’s drug center. Regulation under the agency’s tobacco center could lead to modified risk status, but might make the NDA route more appealing.
Company Information
- Industry
- Diversified
- Other Names / Subsidiaries
-
- John Middleton
- Nat Sherman
- Philip Morris Capital Corporation
- Philip Morris USA
- Ste. Michelle Wine Estates
- U.S. Smokeless Tobacco Company
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice